 |
인쇄하기
취소
|
HIRAS selects 10 BPH based subjects
The Health Insurance Review Assessment and Service said on April 15 that it will evaluate the following ten healthcare subjects, such as therapeutic interventions, diagnostic test and medicinal products, based on the evidence based healthcare.
The selected subjects include autoimmune test, platelet agglutination and coagulation test, proton therapy for pediatric tumor, chemotherapy in color...
The selected subjects include autoimmune test, platelet agglutination and coagulation test, proton therapy for pediatric tumor, chemotherapy in color...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.